NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of UnitedHealth Group Inc. (NYSE: UNH)?Did you purchase your shares between March 14, 2022 and February 27, 2024, inclusive?Did you lose money in your investment in UnitedHealth Group Inc.?Do you want to discuss your rights? Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the common stock of UnitedHealth Group Inc. (“United ...

In the latest trading session, UnitedHealth Group (UNH) closed at $497.44, marking a +0.42% move from the previous day. This move outpaced the S&P 500's daily gain of 0.11%. Meanwhile, the Dow experienced a drop of 0.3%, and the technology-dominated Nasdaq saw an increase of 0.56%.Shares of the largest U.S. health insurer witnessed a gain of 0.59% over the previous month, trailing the performance of the Medical sector with its gain of 2.86% and the S&P 500's gain of 5.06%.Investors will be eagerly watching ...

Senate Finance Committee Chair Ron Wyden, D-Ore., has called on the Biden administration to investigate the cybersecurity incident at UnitedHealth Group.In a Thursday (May 30) letter addressed to Federal Trade Commission (FTC) Chair Lina M. Khan and Securities and Exchange Commission (SEC) Chair Gary Gensler, Wyden asked that the two agencies investigate the incident.Wyden wrote in the letter that the incident was “completely preventable and the direct result of corporate negligence,” noting that UnitedHeal ...

Key TakeawaysShares of health insurers dropped Wednesday after the CEO of UnitedHealth Group warned about lower premium payments as Medicaid rolls shrink.UnitedHealth Group CEO Andrew Witty reportedly told a conference in New York that the health insurance industry will face a "disturbance" because of the changes in Medicaid patient numbers.UnitedHealth Group stock was the biggest drag on the Dow Wednesday, which fell over 1%. Health insurance stocks dropped Wednesday after the head of UnitedHealth Group (U ...

NEW YORK, May 29, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of UnitedHealth Group Inc. (NYSE: UNH).Shareholders who purchased shares of UNH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/unitedhealth-group-inc-loss-submission-form/?id=81733&from=4CLASS PERIOD: March 14, 20 ...

LOS ANGELES, May 28, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against UnitedHealth Group Incorporated ("UnitedHealth" or the "Company") (NYSE: UNH).Class Period: March 14, 2022 – February 27, 2024Lead Plaintiff Deadline: July 15, 2024If you are a shareholder who suffered a loss, click here to participate.The complaint filed alleges that, throughout the Class Period, Defendants fai ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased UnitedHealth Group Inc. common stock between March 14, 2022, and February 27, 2024, of the July 15, 2024, deadline to serve as lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought UnitedHealth common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by July 15, 2024, to serve as lead plaintiff [2] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for securities class action settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3] Group 3: Case Allegations - The lawsuit alleges that UnitedHealth misrepresented its efforts to prevent anti-competitive behavior, claiming it had established "robust firewall processes" to protect customer sensitive information after its acquisition of Change Healthcare [4] - UnitedHealth's assurances led to artificially inflated stock prices during the class period, resulting in investor damages when the true details were revealed [4]

Core Viewpoint - UnitedHealth Group's subsidiary, UnitedHealthcare, has secured a contract from the State of Kansas to provide services for the Medicaid and Children's Health Insurance Program, effective from early 2025, which is expected to enhance health outcomes for members through collaboration with local providers and organizations [1][2]. Group 1: Contract and Membership Impact - The renewal of the KanCare contract is attributed to UnitedHealthcare's extensive experience of over a decade serving its members, which is likely to expand its customer base and increase premiums, significantly contributing to revenue growth [2]. - As of March 31, 2024, UnitedHealthcare's Medicaid membership stood at 7.7 million, with overall premiums for UnitedHealth Group increasing by 7.1% year over year in the first quarter [2][3]. - The contract win is expected to strengthen UnitedHealth Group's presence in Kansas, where it already has a substantial membership base and provider network [2]. Group 2: Operational Network and Strength - UnitedHealthcare operates a network of 150 hospitals and over 22,000 physicians and care providers in Kansas, serving more than 570,000 residents across various benefit plans [3]. - The strength of UnitedHealthcare's Medicaid business, bolstered by community partnerships and investments, has led to multiple contract wins, including being one of three managed care organizations selected for the KanCare contract [3]. Group 3: Stock Performance - UnitedHealth Group's shares have increased by 4% over the past month, outperforming the industry growth of 3.3% [4].

Company Overview - UnitedHealth Group Incorporated (UNH) is the largest player in the health insurance industry, with a market capitalization exceeding that of all its publicly listed competitors combined [3] - The company operates in a sector expected to grow significantly due to an aging global population and increasing rates of chronic diseases, with the global health insurance market projected to grow from $1.8 trillion in 2024 to $3.2 trillion by 2032, representing a compound annual growth rate of 6.2% [3] Financial Performance - In Q1 2024, UNH reported total revenues of $99.8 billion, an increase of 8.6% year-over-year, surpassing analyst expectations by $490 million [7] - The company has consistently exceeded analyst consensus for revenue and non-GAAP EPS, achieving revenue beats in 17 of the last 19 quarters and non-GAAP EPS beats in all 19 quarters leading up to Q1 2024 [7] - Adjusted diluted EPS for Q1 2024 was $6.91, reflecting a 10.4% increase from the previous year and exceeding analyst consensus by $0.29 [11] Membership and Market Segments - Total medical membership declined by 2.7% to 51.5 million, primarily due to the sale of its Brazil operations and increased redeterminations in Medicaid [9] - Domestic commercial members increased by 2.1 million, and Medicare Advantage membership rose by 2.8% to 7.8 million [10] - The number of people served through UnitedHealthcare's domestic commercial offerings and Medicare Advantage contributed to revenue growth, despite declines in global membership [8] Growth Projections - Analysts project adjusted diluted EPS to rise by 10.5% in 2024 to $27.75, with further increases anticipated in 2025 and 2026 [12] - The company's annual growth consensus is 12.2% for the next three years, supported by steady revenue growth and share buybacks [13] Valuation and Dividend Growth - UNH shares are currently trading at a P/E ratio of 18.6, below the 10-year normal P/E ratio of 20.2, suggesting potential for price appreciation [13] - The company has a five-year compound annual growth rate of dividends at 15.9%, significantly higher than the healthcare sector median of 6.6% [14] - A projected 13.3% increase in the quarterly dividend per share to $2.13 is anticipated, maintaining a sustainable payout ratio [14]

Core Viewpoint - UnitedHealth Group (UNH) is currently rated as a STRONG BUY by Wall Street analysts, with a score of 4.55, reflecting strong sentiment and confidence in the stock's long-term earning power and reasonable valuation following recent price corrections [3][4]. Analyst Ratings - Out of 27 analysts, 17 recommend Strong Buy, 8 recommend Buy, 2 recommend Hold, and none recommend Sell or Strong Sell, indicating a predominantly positive outlook [3]. Earnings Outlook - Analysts project a steady EPS growth for UNH at a CAGR of 9.5% over the next decade, supported by the company's scale and differentiated business model, particularly its vertical integration and data-driven approach [5][10]. Valuation Metrics - UNH is currently trading at a forward P/E of 18.8x, which is approximately 6% lower than the sector median of 19.9x and about 7% lower than its 5-year average P/E of 20.2x, suggesting a slight discount in valuation [7][8]. Cash Flow Analysis - The two-stage discounted free cash flow model estimates UNH's fair price at around $766 per share, compared to its current price of $581, indicating a significant margin of safety [12][16]. Medical Cost Ratio - By the end of 2023, UNH's medical cost ratio averaged 83.2%, up from 82.0% the previous year, with a peak of 85.0% in December, attributed to increased insurance usage as the pandemic recedes [4][10]. Competitive Advantages - UNH's competitive edge lies in its vertical integration and investment in technology and data analytics, which enhance care coordination and optimize health outcomes, positioning the company favorably in the evolving healthcare landscape [5][10]. Future Growth Projections - The projected free cash flow per share is expected to grow from $27.60 in 2023 to $68.40 by 2032, reflecting a robust growth trajectory [16].